Thorough QT/QTc study for Garenoxacin.

Trial Profile

Thorough QT/QTc study for Garenoxacin.

Phase of Trial: Phase III

Latest Information Update: 11 Jul 2011

At a glance

  • Drugs Garenoxacin; Moxifloxacin
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Gram-negative infections; Gram-positive infections; Intra-abdominal infections; Otorhinolaryngological infections; Pelvic inflammatory disorders; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Schering-Plough
  • Most Recent Events

    • 11 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top